Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Logout MarketXLS
Amgen Inc. logo

Amgen Inc.

Sector: 
Healthcare
   

Industry: 
Biotechnology

285.94
 
USD
  
-0.46
  
(-0.16%)
Optionable: Yes  Market Cap: 150,464 M  90-day average vol: 2,833,333

Previous close: 286.4  Open: 288.0  Bid: 285.67  Ask: 285.67
52 week range    
200.84   
   296.67
Peers   
BMY / 
PFE / 
GSK / 
GILD / 
ABBV / 
BIIB / 
JNJ / 
ILMN / 
ABT / 
Last updated: Friday 2nd December 2022
62
MarketXLS Rank marketxls
55
Value marketxls
84
Technical marketxls
47
Quality marketxls

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock
Are you?
twitterstocktwits
Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ABBV

0.0401242 B33.1142.53

ABT

0.0147225 B32.4128.05

BIIB

34 B21.6221.3

BMY

0.0332145 B-27.366.19

GILD

0.044486 B11.763.76

GSK

ILMN

56 B57.3355.92

JNJ

0.0247450 B22.1171.06

LLY

0.0161238 B37.4243.55

PFE

0.0302298 B15.153.21
News
Financials

AMGN Income Statement

Annual

Dec-12Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21
Total revenues17,265 M18,676 M20,063 M21,662 M22,991 M22,849 M23,747 M23,362 M25,424 M25,979 M
Cost of sales2,111 M2,060 M2,330 M2,119 M2,057 M2,114 M2,155 M2,150 M2,558 M3,056 M
Gross operating profit13,440 M14,846 M14,905 M16,717 M17,730 M17,726 M18,432 M17,848 M18,081 M17,843 M
Selling Gen & administrative expense5,109 M5,380 M5,153 M4,895 M5,195 M5,245 M5,646 M5,216 M5,919 M5,562 M
Research & development expense3,380 M4,083 M4,297 M4,070 M3,840 M3,562 M3,737 M4,116 M4,207 M4,819 M
Operating income5,577 M5,867 M6,191 M8,470 M9,794 M9,973 M10,263 M9,674 M9,139 M9,144 M
floaterest income0000000000
floaterest expense0000000000
Other income net00000000256 M-1,246 M
Pre-tax Income (EBT)5,009 M5,265 M5,585 M7,978 M9,163 M9,597 M9,545 M9,138 M8,133 M6,701 M
Income taxes664 M184 M427 M1,039 M1,441 M7,618 M1,151 M1,296 M869 M808 M
Net income from total operations4,345 M5,081 M5,158 M6,939 M7,722 M1,979 M8,394 M7,842 M7,264 M5,893 M
Minority floaterest0000000000
Total net income4,345 M5,081 M5,158 M6,939 M7,722 M1,979 M8,394 M7,842 M7,264 M5,893 M
Preferred dividendsN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net income available for common4,345 M5,081 M5,158 M6,939 M7,722 M1,979 M8,394 M7,842 M7,264 M5,893 M
Depreciation1,088 M1,286 M2,092 M2,108 M2,105 M1,955 M1,946 M2,206 M3,601 M3,398 M
Amortization294 M000000000
Operating income before depreciation (EBITDA)7,150 M7,573 M8,748 M11,181 M12,528 M12,856 M12,883 M12,633 M12,996 M11,296 M
Total Income available for floaterest expense (EBIT)0000000000
Basic EPS total5.616.756.89.1510.322.7112.712.9612.410.34
Diluted EPS total5.526.646.79.0610.242.6912.6212.8812.3110.28
Call: 1-877-778-8358
Ankur Mohan MarketXLS
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and starter sheets.
Get started today